Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.
2.

The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.

Ryoo JH, Choi JM, Moon SY, Suh YJ, Shin JY, Shin HC, Park SK.

Atherosclerosis. 2013 Apr;227(2):398-403. doi: 10.1016/j.atherosclerosis.2013.01.002. Epub 2013 Jan 18.

PMID:
23390894
3.

Nonalcoholic fatty liver disease in patients with type 2 diabetes.

Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ.

Clin Gastroenterol Hepatol. 2004 Mar;2(3):262-5. Erratum in: Clin Gastroenterol Hepatol. 2004 Jun;2(6):522.

PMID:
15017611
4.

Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension.

Ryoo JH, Ham WT, Choi JM, Kang MA, An SH, Lee JK, Shin HC, Park SK.

J Korean Med Sci. 2014 Jul;29(7):973-9. doi: 10.3346/jkms.2014.29.7.973. Epub 2014 Jul 11.

5.

Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.

Arase Y, Suzuki F, Ikeda K, Kumada H, Tsuji H, Kobayashi T.

J Gastroenterol. 2009;44(10):1064-70. doi: 10.1007/s00535-009-0091-1. Epub 2009 Jun 17.

PMID:
19533014
6.

Clinical association between non-alcoholic fatty liver disease and the development of hypertension.

Ryoo JH, Suh YJ, Shin HC, Cho YK, Choi JM, Park SK.

J Gastroenterol Hepatol. 2014 Nov;29(11):1926-31. doi: 10.1111/jgh.12643.

PMID:
24910023
7.

Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.

Chang Y, Jung HS, Yun KE, Cho J, Cho YK, Ryu S.

Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.

PMID:
24100261
8.

A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers.

Chang Y, Ryu S, Zhang Y, Son HJ, Kim JY, Cho J, Guallar E.

PLoS One. 2012;7(5):e37241. doi: 10.1371/journal.pone.0037241. Epub 2012 May 15.

9.

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study.

Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW, Park SW, Kim SW.

Diabetes Care. 2011 Mar;34(3):727-9. doi: 10.2337/dc10-1991. Epub 2011 Jan 28.

10.

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup.

Yamada T, Fukatsu M, Suzuki S, Wada T, Yoshida T, Joh T.

J Gastroenterol Hepatol. 2010 Feb;25(2):352-6. doi: 10.1111/j.1440-1746.2009.05998.x. Epub 2009 Oct 9.

PMID:
19817963
12.

The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.

Arase Y, Suzuki F, Kobayashi M, Suzuki Y, Kawamura Y, Matsumoto N, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto Y, Amakawa K, Tsuji H, Hsieh SD, Kato K, Tanabe M, Ogawa K, Hara S, Kobayashi T.

Intern Med. 2011;50(10):1081-7. Epub 2011 May 1.

13.

Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up.

Zelber-Sagi S, Lotan R, Shibolet O, Webb M, Buch A, Nitzan-Kaluski D, Halpern Z, Santo E, Oren R.

Liver Int. 2013 Oct;33(9):1406-12. doi: 10.1111/liv.12200. Epub 2013 May 8.

PMID:
23656177
14.

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.

Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.

PMID:
18752331
15.

The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly.

Motta M, Bennati E, Cardillo E, Ferlito L, Malaguarnera M.

Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):60-4. doi: 10.1016/j.archger.2009.01.012. Epub 2009 Apr 3.

PMID:
19344959
16.

Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study.

Lee YI, Lim YS, Park HS.

J Gastroenterol Hepatol. 2012 Jan;27(1):91-5. doi: 10.1111/j.1440-1746.2011.06816.x.

PMID:
21679251
17.

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.

Balkau B, Lange C, Vol S, Fumeron F, Bonnet F; Group Study D.E.S.I.R.

BMC Gastroenterol. 2010 Jun 7;10:56. doi: 10.1186/1471-230X-10-56.

18.

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Moon SS, Lee YS, Kim SW.

Endocrine. 2012 Oct;42(2):423-9. Epub 2012 Mar 11.

PMID:
22407492
19.

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).

Raszeja-Wyszomirska J, Szymanik B, Ɓawniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M.

BMC Gastroenterol. 2010 Jun 28;10:67. doi: 10.1186/1471-230X-10-67.

20.

Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population.

Ma H, Xu C, Xu L, Yu C, Miao M, Li Y.

BMC Gastroenterol. 2013 Jan 7;13:3. doi: 10.1186/1471-230X-13-3.

Items per page

Supplemental Content

Write to the Help Desk